logo
Raymond James Lifts Ciena Corporation (CIEN)'s Price Target To $83, Maintains Outperform Rating

Raymond James Lifts Ciena Corporation (CIEN)'s Price Target To $83, Maintains Outperform Rating

Yahoo5 days ago

On Thursday, analysts at Raymond James raised Ciena Corporation (NYSE:CIEN)'s price target to $83 from $79, while maintaining an Outperform rating for the stock. The revised price target represents a 14% upside potential from its current trading value.
A team of telecom engineers discussing a communication infrastructure diagram.
Raymond James' adjustment follows Ciena Corporation (NYSE:CIEN)'s Q2 FY25 earnings call on June 5, in which the company reported revenue of $1.13 billion, up 23.6% year-over-year, driven by accelerating demand in cloud and AI.
However, Ciena Corporation (NYSE:CIEN)'s adjusted earnings per share of $0.42 missed analysts' estimates by 9 cents, overshadowing the impressive revenue growth. The company's gross margin also declined to 41% from 43.5% in the prior year's quarter. Shares crashed nearly 13% on Wednesday to close at $73.05.
Despite disappointing investors, the stock has demonstrated remarkable strength over the past year, gaining over 51% during the period. Raymond James analysts remain confident about the company's growth prospects, given its technology leadership and favorable market trends. They expressed optimism about Ciena Corporation (NYSE:CIEN)'s long-term potential, citing its strong strategic position in the industry.
Ciena Corporation (NYSE:CIEN) is a network technology company that provides hardware, software, and services to a range of network operators.
While we acknowledge the potential of CIEN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: ChatGPT Stock Advice: Top 12 Stock Recommendations and 10 Cheap Rising Stocks to Buy Right Now.
Disclosure: None.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week

Yahoo

time11 minutes ago

  • Yahoo

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week

IQVIA Holdings experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade talks and overall strong corporate earnings have supported the upward trend, further enhancing IQV's market performance. We've identified 1 warning sign for IQVIA Holdings that you should be aware of. Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. The recent 10% rise in IQVIA Holdings' share price has been influenced by important developments like the dosing in the RENEW Phase 2 trial and a key alliance with Sarah Cannon Research Institute. These initiatives are expected to potentially drive revenue growth, particularly as the strategic alliance optimizes oncology trials. The company's past performance, with total returns of 10.45% over five years, suggests modest growth in investor value. However, compared to the US Life Sciences industry's one-year return of 27% decline, IQVIA's recent rise highlights positive market sentiment. These initiatives, combined with FDA reforms and NVIDIA collaboration, may lower operational costs and have a favorable impact on earnings forecasts. Analysts predict revenue to grow by 5.2% annually over the next three years, which is somewhat cautious compared to the general expectations for the life sciences sector. The recent share price movement to US$146.2 remains below the consensus price target of US$216.31, indicating potential for future appreciation if the projected growth in revenue and earnings materializes. Click here to discover the nuances of IQVIA Holdings with our detailed analytical financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:IQV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

The copper market shows how tariffs are putting traders and businesses in a bind
The copper market shows how tariffs are putting traders and businesses in a bind

CNBC

time14 minutes ago

  • CNBC

The copper market shows how tariffs are putting traders and businesses in a bind

Lingering uncertainty over the 90-day suspension of President Trump's high tariffs could scramble some traditional market signals as traders and businesses try to get ahead of government policy. Copper is one asset caught up in such a push-pull scenario, according to Morgan Stanley. The metal, sometimes referred to as " Dr. Copper ," has a history of serving as a leading economic indicator due to its wide use in industry. Viewed from that lens, it should be bolstering confidence on Wall Street right now. The front-month contract for copper futures has gained more than 5% since early May — though it is still well below its high of the year reached in late March, right before tariff fears shook markets. @HG.1 YTD mountain Copper futures are trending higher over the past month, though still below the highs of the year. Equities tied to copper are also doing well, with Freeport-McMoRan up more than 11% over the past month, and Southern Copper higher by 8%. However, reality may not be that simple. Amy Gower, commodities strategist at Morgan Stanley, said in a note to clients Tuesday that several factors are muddying the picture for copper, including "front-loading" from U.S. companies who are buying up the metal now, before potential new tariffs take effect. "Copper faces diverging market forces. [London Metal Exchange] inventories are depleting rapidly as copper is pulled to the U.S., boosting timespreads and prices, but China market signals are weakening, suggesting downside risks to come," Gower said. In February, President Donald Trump signed an executive order directing the Commerce Department to look into the possible need for tariffs on copper. That levy would be separate from, and possibly in addition to, the tariffs on shipments from individual countries. If companies keep buying up copper for fear of future tariffs, that could create an "upward squeeze," Gower said. But the supply-demand picture could also change quickly and pull prices down instead. "Already in April, China exported 77kt of copper, and this will likely have continued in May/June, which may provide some relief to LME inventories. On top [of that], the strong solar installations (+70% YTD in Jan-April) are expected to slow from June as new power tariffs come in ... while U.S. demand will slow if copper tariffs are announced," Gower said. — CNBC's Michael Bloom contributed reporting.

Trump's CFTC pick calls for comprehensive crypto rules in nomination hearing: CNBC Crypto World
Trump's CFTC pick calls for comprehensive crypto rules in nomination hearing: CNBC Crypto World

CNBC

time19 minutes ago

  • CNBC

Trump's CFTC pick calls for comprehensive crypto rules in nomination hearing: CNBC Crypto World

On today's episode of CNBC Crypto World, major cryptocurrencies climb as investors wait for more insight on trade discussions between the U.S. and China. Plus, Brian Quintenz, President Trump's pick to lead the U.S. Commodity Futures Trading Commission, prepares to testify before the Senate. And, Matt Hougan, Bitwise Asset Management CIO, discusses the launch of the asset manager's new GameStop-focused covered call ETF.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store